Ulinastatin is a novel candidate drug for sepsis and secondary acute lung injury, evidence from an optimized CLP rat model
Ning Wang(Shanghai Ninth People's Hospital), Jiang Zheng(Guiyang College of Traditional Chinese Medicine), Yuanfeng Zhu(Army Medical University), Shijun Fan(Army Medical University), Hongwei Cao(Tianjin University), Hong Zhou(Nanjing Agricultural University), Xinchuan Zheng(Army Medical University), Xin Liu(Army Medical University), Wei Guo(Army Medical University)
Cited by 37
Related Papers
Subunit Vaccines Against Emerging Pathogenic Human Coronaviruses
|Frontiers in Microbiology|2020|442
Distinct biophysical mechanisms of focal adhesion kinase mechanoactivation by different extracellular matrix proteins
|Proceedings of the National Academy of Sciences|2013|199
Circulating exosomes contain protein biomarkers of metastatic non‐small‐cell lung cancer
|Cancer Science|2018|137
Green Tea and Epigallocatechin Gallate (EGCG) for the Management of Nonalcoholic Fatty Liver Diseases (NAFLD): Insights into the Role of Oxidative Stress and Antioxidant Mechanism
|Antioxidants|2021|134
Inflammation: A Novel Therapeutic Target/Direction in Atherosclerosis
|Current Pharmaceutical Design|2017|132